NanoCellect Biomedical Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
75
- Latest Deal Type
-
Series AA
- Latest Deal Amount
-
$28.9M
- Investors
-
27
NanoCellect Biomedical General Information
Description
Developer of microfluidic flow cytometry devices designed to facilitate biomedical breakthroughs with simplified cell analysis and sorting. The company's devices utilize microfluidics with an integrated sorting system that simplifies the process of analyzing and sorting distinct populations of cells from a heterogeneous population, enabling biomedical scientists to easily explore and sort cells required for drug discovery, diagnostics, or basic research.
Contact Information
Website
www.nanocellect.comCorporate Office
- 9525 Towne Centre Drive
- Suite 150
- San Diego, CA 92121
- United States
Corporate Office
- 9525 Towne Centre Drive
- Suite 150
- San Diego, CA 92121
- United States
NanoCellect Biomedical Timeline
NanoCellect Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 18. Later Stage VC (Series AA) | 29-Jun-2023 | $28.9M | Completed | Generating Revenue | ||
| 17. Grant | 01-Jan-2022 | Completed | Generating Revenue | |||
| 16. Later Stage VC (Series D) | 27-Aug-2021 | Completed | Generating Revenue | |||
| 15. Later Stage VC (Series C) | 01-Feb-2021 | Completed | Generating Revenue | |||
| 14. Grant | 04-Oct-2019 | Completed | Generating Revenue | |||
| 13. Grant | 01-Jan-2018 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series B) | 29-Nov-2017 | Completed | Generating Revenue | |||
| 11. Grant | 01-Jan-2017 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series A) | 22-Jan-2016 | $1.75M | $1.75M | Completed | Generating Revenue | |
| 9. Grant | 01-Jan-2016 | $10M | Completed | Generating Revenue |
NanoCellect Biomedical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Junior Preferred | ||||||||
| AA-2 Preferred | ||||||||
| AA-1 Preferred | 124,401,909 | $0.000010 | 6% | $0.21 | $0.21 | 1x | $0.21 | 33.72% |
NanoCellect Biomedical Comparisons
Industry
Financing
Details
NanoCellect Biomedical Competitors (30)
One of NanoCellect Biomedical’s 30 competitors is Diagnostic Automation / Cortez Diagnostics, a Corporation company based in Calabasas, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Diagnostic Automation / Cortez Diagnostics | Corporation | Calabasas, CA | ||||
| CivaTech Oncology | Venture Capital-Backed | Durham, NC | ||||
| S2 Genomics | Venture Capital-Backed | Livermore, CA | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| ViewRay | Formerly VC-backed | Bedford, OH |
NanoCellect Biomedical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NanoCellect Biomedical Patents
NanoCellect Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4168247-A1 | Microfluidic systems and methods for sorting particles | Pending | 18-Jun-2020 | ||
| CA-3183080-A1 | Microfluidic systems and methods for sorting particles | Pending | 18-Jun-2020 | ||
| US-20230234056-A1 | Microfluidic systems and methods for sorting particles | Pending | 18-Jun-2020 | ||
| EP-4168247-A4 | Microfluidic systems and methods for sorting particles | Pending | 18-Jun-2020 | ||
| US-20200200670-A1 | Systems, apparatuses, and methods for cell sorting and flow cytometry | Active | 20-Mar-2017 | G01N15/1425 |
NanoCellect Biomedical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NanoCellect Biomedical Investors (27)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BroadOak Capital Partners | Growth/Expansion | Minority | ||
| Paladin Capital Group | Venture Capital | Minority | ||
| Casdin Capital | Venture Capital | Minority | ||
| Warburg Pincus | PE/Buyout | Minority | ||
| Windward Capital Ventures | PE/Buyout | Minority |
NanoCellect Biomedical FAQs
-
When was NanoCellect Biomedical founded?
NanoCellect Biomedical was founded in 2009.
-
Where is NanoCellect Biomedical headquartered?
NanoCellect Biomedical is headquartered in San Diego, CA.
-
What is the size of NanoCellect Biomedical?
NanoCellect Biomedical has 75 total employees.
-
What industry is NanoCellect Biomedical in?
NanoCellect Biomedical’s primary industry is Other Devices and Supplies.
-
Is NanoCellect Biomedical a private or public company?
NanoCellect Biomedical is a Private company.
-
What is the current valuation of NanoCellect Biomedical?
The current valuation of NanoCellect Biomedical is .
-
What is NanoCellect Biomedical’s current revenue?
The current revenue for NanoCellect Biomedical is .
-
How much funding has NanoCellect Biomedical raised over time?
NanoCellect Biomedical has raised $75.7M.
-
Who are NanoCellect Biomedical’s investors?
BroadOak Capital Partners, Paladin Capital Group, Casdin Capital, Warburg Pincus, and Windward Capital Ventures are 5 of 27 investors who have invested in NanoCellect Biomedical.
-
Who are NanoCellect Biomedical’s competitors?
Diagnostic Automation / Cortez Diagnostics, CivaTech Oncology, S2 Genomics, Illumina, and ViewRay are some of the 30 competitors of NanoCellect Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
